News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Flugen, Inc. Applauds Efforts to Accelerate Cell-Based Influenza Vaccine Production



4/30/2009 9:47:48 AM

MADISON, Wis.--(BUSINESS WIRE)--The following is a statement by Paul V. Radspinner, president and chief executive of Madison, Wis.-based FluGen Inc., regarding the request made of Congress yesterday by President Obama for $1.5 billion in emergency funding to combat the growing swine flu outbreak. FluGen was co-founded by Dr. Yoshihiro Kawaoka, the world-renowned influenza researcher who established the “reverse genetics” method that revolutionized influenza research.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES